期刊文献+

血清尿游离轻链检测在结缔组织病中的临床意义 被引量:1

The clinical significance of serum and urine free light chain detection in connective tissue disease
下载PDF
导出
摘要 目的探讨血清、尿游离轻链检测的临床应用。方法利用速率散射比浊法对临床确诊的45例结缔组织病(CTD)及43例多发性骨髓瘤(MM)患者血清和尿液中游离轻链进行测定。结果 CTD组血清与尿κ型轻链含量明显低于κ型MM组(P<0.05),CTD组血清与尿λ型轻链含量亦明显低于λ型MM组(P<0.05);CTD组血清与尿κ/λ比值低于κ型MM组(P<0.05),高于λ型MM组(P<0.05)。45例CTD组血清轻链检测无一例表现为κ/λ比值失衡,而43例MM组中有41例表现为比例失衡。结论对免疫球蛋白明显升高的CTD,为了解是否同时存在MM,血清与尿κ、λ及κ/λ比值测定有临床应用价值。 Objective To discuss the clinical application of serum and urine free light chain detection.Methods The levels of free light chain in serum and urine were measured in the cases of connective tissue disease(CTD)and multiple myeloma (MM)by nephelometry. Results The levels of light chainκin serum and urine of CTD patients were lower than those of type κMMpatients(P<0.05).The levels of light chain λin serum and urine of CTD patients were also lower than those of type λMM patients(P<0.05).The serum and urineκ/λratio of CTD patients was lower than that of type κMM patients (P<0.05 ),but higher than that of type λMM patients (P<0.05 ). There was no one ratio imbalance of the serumκ/λin CTD patients,while there were 41 in MM patients.Conclusion For CTD in which im-mune globulin is significantly high,light chain testing can help to understand whether MMexists.The serum and urineκ,λandκ/λratio have value in clinical application.
出处 《安徽医学》 2014年第6期737-739,共3页 Anhui Medical Journal
关键词 免疫球蛋白 游离轻链 结缔组织病 多发性骨髓瘤 Immune globulin Free light chain Connective tissue diseases Multiple myeloma
  • 相关文献

参考文献7

二级参考文献32

  • 1Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med, 1978,89 (6) : 888-892. 被引量:1
  • 2Kovacs L, Szodoray P, Kiss E. Secondary tumours in Sjogren's syndrome. Autoimmun Rev, 2010,9(4 ) : 203-206. 被引量:1
  • 3Voulgarelis M, Dafni UG, Isenberg DA, et al. Malignant lym- phoma in primary Sjogren's syndrome: a muhicenter, retro- spective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum, 1999,42(8 ) : 1765-1772. 被引量:1
  • 4Sutcliffe N, Inanc M, Speight P, et al. Predictors of lymphoma development in primary SjogrenJs syndrome. Semin Arthritis Rheum, 1998,28(2 ) : 80-87. 被引量:1
  • 5Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in pa- tients with Sjogren's syndrome are marginal zone B-cell neo- plasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood, 1997,90(2 ) : 766-775. 被引量:1
  • 6Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lym- phoid malignancies. Int J Cancer, 2009,125 (2) : 398-405. 被引量:1
  • 7Skopouli FN, Dafni U, Ioannidis JP, et al. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum, 2000,29(5 ) : 296-304. 被引量:1
  • 8Tzioufas AG, Boumba DS, Skopouli FN, et al. Mixed mono- clonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the develop- ment of lymphoma in primary Sjogren's syndrome. Arthritis Rheum, 1996,39(5 ) : 767-772. 被引量:1
  • 9Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis, 2003,62 ( 2 ) : 168-171. 被引量:1
  • 10Szodoray P, Jellestad S, Teague MO, et al. Attenuated apopto- sis of B cell activating factor-expressing cells in primary Sjo- gren's syndrome. Lab Invest, 2003,83( 3 ) : 357-365. 被引量:1

共引文献6

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部